Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.
De Luca I, Di Carlo F, Burkauskas J, Dores AR, Carvalho IP, Gómez-Martínez MÁ, Szabo A, Fujiwara H, Barbosa CM, Di Nicola M, Mazza M, Sani G, Luciani D, Pettorruso M, di Giannantonio M, Cataldo I, Esposito G, Martinotti G, Zandonai T, Rabin O, Corazza O.
De Luca I, et al. Among authors: rabin o.
Front Public Health. 2024 Jun 19;12:1386721. doi: 10.3389/fpubh.2024.1386721. eCollection 2024.
Front Public Health. 2024.
PMID: 38962770
Free PMC article.